Dependence on Exparel for growth remains a concern for Pacira. Any setback for the drug will weigh heavily on the stock.

The forex headwinds, customer concentration, integration issues and end-market uncertainty may somewhat hamper its revenue growth.

Lower potash and phosphate prices may impact the company's margins.  Production cuts at Colonsay may affect potash volumes.

Lower fertilizer prices are likely to put pressure on the company's margins. Its high debt level is another concern.

Medifast is encountering difficulties in attracting customers, primarily because of a range of macroeconomic elements, such as a rapidly changing economy, inflation, shifts in social media algorithms and fierce competition.

The weakness in the electronics market may affect the company’s results. Element Solutions is also exposed to currency headwinds and high debt levels. 

Huntsman is seeing pressure from lower selling prices. The company also faces headwinds from weak demand in Europe and China. Elevated input costs may also hurt margins.

Alibaba's business structure involves certain risks due to the strict laws in China, which along with lower mobile monetization, increasing competition and integration risks are concerns.

Ciena operates in an intensely competitive market for the sale of communications networking equipment, software and services. Supply chain woes are an added concern.

Rising SG&A costs, fluctuations in foreign exchange rates and stiff competition are major concerns for Penske Automotive.